Aptamer to FGF2 and use thereof
US8772259B2 · kind B2 · utility
0Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2011 |
| Grant date | Jul 8, 2014 |
| Priority date | — |
| Expiry date | Feb 10, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/344
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are an aptamer having an inhibitory activity on FGF2; a complex containing an aptamer having a binding activity or an inhibitory activity on FGF2, and a functional substance (e.g., affinity substance, labeling substance, enzyme, drug delivery vehicle, or drug and the like); a medicament, diagnostic reagent or label containing an aptamer having a binding activity or an inhibitory activity on FGF2, or a complex containing said aptamer and a functional substance; and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.